Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa
Condition(s):Non-syndromic Retinitis PigmentosaLast Updated:July 26, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Non-syndromic Retinitis PigmentosaLast Updated:July 26, 2022Recruiting
Condition(s):Retinitis PigmentosaLast Updated:April 20, 2022Recruiting
Condition(s):Retinitis PigmentosaLast Updated:July 19, 2016Unknown status
Condition(s):Retinitis PigmentosaLast Updated:December 15, 2023Active, not recruiting
Condition(s):Cytomegalovirus RetinitisLast Updated:July 21, 2021Completed
Condition(s):Autosomal Dominant Retinitis PigmentosaLast Updated:November 6, 2013Completed
Condition(s):Retinitis PigmentosaLast Updated:July 21, 2017Completed
Condition(s):Retinitis PigmentosaLast Updated:March 30, 2017Completed
Condition(s):Retinitis PigmentosaLast Updated:September 20, 2011Completed
Condition(s):Retinitis PigmentosaLast Updated:March 4, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.